Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Herendeen currently holds 84,813 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Herendeen has been a net seller of VRX stock. They have purchased $875.2K and sold $17.7M worth of shares.
Paul Herendeen's most recent insider trade was on Nov 28, 2025, when they sold 10,314 shares at $0.00 per share.
Paul Herendeen serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 52 insider transactions totaling $18.5M over their tenure at the company.
Paul Herendeen holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Paul Herendeen has shown a selling trading pattern, with $875.2K in total purchases and $17.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Herendeen was on Mar 16, 2011, when they sold $9.3M worth of WCRX shares. This transaction involved 400,000 shares at $23.25 per share.
Paul Herendeen currently owns 84,813 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Herendeen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Herendeen has 52 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Paul Herendeen and 40,000+ other insiders.